8-KThe WireRoutine
Reg FD Disclosure · Company Update
Filed Sep 9, 2025 · 9mo ago · Accession 0001558370-25-011954
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- ArriVent BioPharma, Inc.
- Ticker
- AVBP
- CIK
- 1868279
- Form type
- 8-K
- Filing date
- Sep 9, 2025
- Report date
- Sep 9, 2025
- Document
- avbp-20250909x8k.htm
- Size
- 196 KB